5th Mar 2020 18:14
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
5 March 2020
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").
On 3 March 2020 the nil cost Conditional Awards over Shares granted on 3 March 2017 and 2 September 2019 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below.
Name | No. of Performance Shares vested | No. of Dividend Equivalent Shares on Performance Shares | No. of Bonus Deferral Shares Vested | No. of Dividend Equivalent Shares on Bonus Deferral Shares | No. of Restricted Shares Vested |
| No. of Shares sold to cover statutory deductions |
Stephen Hester1 | 192,486 | 19,277 | 129,805 | 13,000 | - |
| 167,157 |
Scott Egan1 | 90,685 | 9,081 | 60,482 | 6,057 | - |
| 78,403 |
Martin Thompson | 57,161 | 5,724 | 21,544 | 2,157 | - |
| 46,900 |
Ralph Daals | 29,796 | 2,984 | 9,318 | 933 | - |
| 20,287 |
Charlotte Heiss | 24,224 | 2,425 | 7,499 | 751 | - |
| 16,453 |
William McDonnell | 32,128 | 3,217 | 22,296 | 2,233 | - |
| 28,227 |
Karen Caddick | - | - | 6,091 | 87 | - |
| 2,913 |
Charlotte Jones1,2,3 | 36,622 | 523 | - | - | 22,972 |
| 28,342 |
Nathan Williams | 38,865 | 3,892 | - | - | - |
| 20,158 |
Kenneth Norgrove | 22,057 | 2,209 | 7,687 | 769 | - |
| 17,068 |
· Bonus Deferral Shares granted on 3 March 2017 relate to awards made in respect of 2016 as part of the Annual Bonus Plan.
· Performance Shares vested at 50.3% following testing of Group underlying Return on Tangible Equity (ROTE), Relative Total Shareholder Return (TSR) and Business Scorecard factors.
· The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.
· Shares sold to cover statutory deductions were sold at a price of £5.261779 per share on 3 March 2020.
· Shares retained have been transferred to the Equatex nominee account operated by RSA as part of the share plan administration system.
Notes to table:
1 A two-year retention period applies to vested Performance Shares, excluding any sold to satisfy statutory deductions, in line with the Directors' Remuneration Policy.
2 A six-month retention period applies to 14,277 of the vested Restricted Shares, excluding any sold to satisfy statutory deductions.
3Awarded to compensate for awards forfeited on leaving previous employer, in accordance with the Directors' Remuneration Policy.
The forms required under the EU Market Abuse Regulation follow.
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Stephen Hester | |||||
b) | Position / status | Group Chief Executive | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
192,486
Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
19,277 Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
129,805
Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
13,000
Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
167,157
£5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Scott Egan | |||||
b) | Position / status | CEO, UK and International | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
90,685
Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
9,081
Nil
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) |
Nature of the transaction |
Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
60,482 Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
6,057 Nil | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction |
| |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
78,403 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Martin Thompson | |||||
b) | Position / status | CEO, Canada | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
57,161 NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
5,724 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
21,544 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,157 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
46,900 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Ralph Daals | |||||
b) | Position / status | Group Chief Auditor | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
| |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
29,796 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,984 NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
9,318 NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
933
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) |
Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
20,287 £5.261779
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Charlotte Heiss | |||||
b) | Position / status | Group Chief Legal Officer and Company Secretary | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
24,224
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,425
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
7,499 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23
| |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
751
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
16,453
£5.261779
| |||||
e) | Date of the transaction | 3 March 2020
| |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | William McDonnell | |||||
b) | Position / status | Group Chief Risk Officer | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
32,128 NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
3,217
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) |
Aggregated information - Aggregated volume - Price |
22,296 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,233
NIL
| |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) |
Place of the transaction |
| |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
28,227 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Karen Caddick | |||||
b) | Position / status | Group & UK HR Director | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
6,091 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
87 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,913 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Charlotte Jones | |||||
b) | Position / status | Group Chief Financial Officer | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
36,622 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 3 March 2022. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
523 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Restricted Share awards granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. 14,277 shares are subject to a six month retention period which ends on 3 September 2020, excluding any sold to satisfy statutory deductions.
| |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
22,972 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
28,342 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Nathan Williams | |||||
b) | Position / status | Group Underwriting Director | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
38,865 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
3,892 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
20,158 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
1. | Details of PDMR / Person Closely Associated ("PCA") | ||||||
a) | Name | Kenneth Norgrove | |||||
b) | Position / status | CEO RSA Scandinavia | |||||
c) | Initial notification / amendment | Initial Notification | |||||
2. | Details of the issuer | ||||||
a) | Name | RSA Insurance Group plc | |||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Performance Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
22,057 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
2,209 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
7,687 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 3 March 2017 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
769 NIL | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 3 March 2020 under the RSA Performance Share Plan 2014. | |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information - Aggregated volume - Price |
17,068 £5.261779 | |||||
e) | Date of the transaction | 3 March 2020 | |||||
f) | Place of the transaction | XLON London Stock Exchange | |||||
Enquiries to:
Christopher Smyth, Deputy Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000
Related Shares:
RSA.L